Sifting through countless of stocks in the Life Sciences Tools & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Illumina, Inc. or Bruker Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Illumina, Inc. and Bruker Corporation compare based on key financial metrics to determine which better meets your investment needs.

About Illumina, Inc. and Bruker Corporation

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Latest Life Sciences Tools & Services and Illumina, Inc., Bruker Corporation Stock News

As of June 25, 2026, Illumina, Inc. had a $26.9 billion market capitalization, compared to the Life Sciences Tools & Services median of $1.9 million. Illumina, Inc.’s stock is up 33.9% in 2026, up 8.5% in the previous five trading days and up 94.11% in the past year.

Currently, Illumina, Inc.’s price-earnings ratio is 32.2. Illumina, Inc.’s trailing 12-month revenue is $4.4 billion with a 19.4% net profit margin. Year-over-year quarterly sales growth most recently was 4.8%. Analysts expect adjusted earnings to reach $5.230 per share for the current fiscal year. Illumina, Inc. does not currently pay a dividend.

As of June 25, 2026, Bruker Corporation had a $9.3 billion market cap, putting it in the 77th percentile of all stocks. Bruker Corporation’s stock is up 28.4% in 2026, up 5.7% in the previous five trading days and up 53.53% in the past year.

Currently, Bruker Corporation does not have a price-earnings ratio. Bruker Corporation’s trailing 12-month revenue is $3.5 billion with a -0.3% net profit margin. Year-over-year quarterly sales growth most recently was 2.7%. Analysts expect adjusted earnings to reach $2.117 per share for the current fiscal year. Bruker Corporation currently has a 0.3% dividend yield.

How We Compare Illumina, Inc. and Bruker Corporation Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Illumina, Inc. and Bruker Corporation’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Illumina, Inc. and Bruker Corporation Growth Grades

Company	Ticker	Growth
Illumina, Inc.	ILMN	B
Bruker Corporation	BRKR	A

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Illumina, Inc. has a Growth Score of 61, which is Strong. Bruker Corporation has a Growth Score of 89, which is Very Strong.

The Growth Grade Winner: Bruker Corporation

As you can clearly see from the Growth Grade breakdown above, Bruker Corporation has a more attractive growth grade than Illumina, Inc.. For investors who focus solely on how a company is growing relative to other companies in the same industry, Bruker Corporation could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Illumina, Inc. and Bruker Corporation’s Quality Grades

Company	Ticker	Quality
Illumina, Inc.	ILMN	A
Bruker Corporation	BRKR	B

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Illumina, Inc. has a Quality Score of 95, which is Very Strong. Bruker Corporation has a Quality Score of 64, which is Strong.

The Quality Grade Winner: Illumina, Inc.

As you can clearly see from the Quality Grade breakdown above, Illumina, Inc. has a better overall quality grade than Bruker Corporation. For investors who are looking for companies with higher quality than others in the same industry, Illumina, Inc. could be a good stock to add to their portfolios. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Illumina, Inc. and Bruker Corporation’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Illumina, Inc.	ILMN	B
Bruker Corporation	BRKR	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Illumina, Inc. has a Earnings Estimate Score of 75, which is Positive. Bruker Corporation has a Earnings Estimate Score of 42, which is Neutral.

The Earnings Estimate Revisions Grade Winner: Illumina, Inc.

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Illumina, Inc. has a better Earnings Estimate Revisions Grade than Bruker Corporation. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Illumina, Inc. could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Illumina, Inc. and Bruker Corporation Grades

In addition to Growth, Estimate Revisions and Quality, A+ Investor also provides grades for Value and Momentum.

Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Illumina, Inc. and Bruker Corporation pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Illumina, Inc. or Bruker Corporation Stock?

Overall, Illumina, Inc. stock has a Growth Score of 61, Estimate Revisions Score of 75 and Quality Score of 95.

Bruker Corporation stock has a Growth Score of 89, Estimate Revisions Score of 42 and Quality Score of 64.

Comparing Illumina, Inc. and Bruker Corporation’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.